Serodiagnosis of Lyme borreliosis—is IgM in serum more harmful than helpful?

[1]  R. Dessau,et al.  To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis: a position paper of ESGBOR, the ESCMID study group for Lyme borreliosis. , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[2]  J. Hovius,et al.  Borrelia burgdorferi sensu lato serology in the Netherlands: guidelines versus daily practice , 2014, European Journal of Clinical Microbiology & Infectious Diseases.

[3]  O. Vandenberg,et al.  Evaluation of commercial screening tests and blot assays for the diagnosis of Lyme borreliosis. , 2012, Diagnostic microbiology and infectious disease.

[4]  M. Hommes,et al.  Large differences between test strategies for the detection of anti-Borrelia antibodies are revealed by comparing eight ELISAs and five immunoblots , 2011, European Journal of Clinical Microbiology & Infectious Diseases.

[5]  G Stanek,et al.  Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[6]  M. Petzke.  - 1-Utilization of serology for the diagnosis of suspected Lyme borreliosis in Denmark : Prospective survey of patients seen in general practice , 2009 .

[7]  U. Ljøstad,et al.  Chronic polyneuropathy and Lyme disease , 2006, European journal of neurology.

[8]  I. Eliasson,et al.  C6 peptide ELISA test in the serodiagnosis of Lyme borreliosis in Sweden , 2006, European Journal of Clinical Microbiology & Infectious Diseases.